“…We also found that among AA patients, patients who used CHMs had lower risks of overall and anemia-related mortalities even after adjusting for age, gender, comorbidities, and usages of immunosuppressive therapy, glucocorticoid usage, hematopoietic growth factor therapy, androgen therapy, chemotherapy, iron chelation therapy, and blood transfusion therapy. CHMs may show the protective effect against bone marrow failure related diseases (Gao and Chong, 2012;Kuang et al, 2016;Sun et al, 2018;Jiang et al, 2021). Ginseng extract and its active component-panaxadiol saponins promote the proliferation and differentiation of hematopoietic progenitor cells and then regulate the immune function (Gao and Chong, 2012;Kuang et al, 2016;Sun et al, 2018;Jiang et al, 2021).…”